Successful Crackdown on Illegal Use of Methylphenidate

Regulations by 2FIRSTS.ai
Nov.20.2023
Successful Crackdown on Illegal Use of Methylphenidate
Seven suspects were arrested in Ganzhou, Jiangxi for illegal use of illicit substance meprobamate in e-cigarette manufacturing.

According to the news on November 20th from Guizhou Internet Radio and Television Station, the Xinfeng police in Ganzhou, Jiangxi recently successfully cracked a case involving the use of methyl ethyl ketone to produce "Shangtou e-cigarettes". In total, seven suspects involved in illegal activities were arrested.

Successful Crackdown on Illegal Use of Methylphenidate

 

According to data from the police, the urine test results of arrested suspects have all shown positive for eutylone. On the other hand, cases related to eutylone have also been successively cracked in Xishui, Hubei and Yuncheng, Guangdong, once again highlighting the dangers of eutylone in the illegal market.

 

Dependence on Etomidate", known as a type of prescription anesthetic, can only be legally used by medical institutions that have obtained a "Pharmaceutical Business License." Similarly, only pharmaceutical wholesale and retail enterprises with a "Pharmaceutical Business License" can sell raw materials and preparations of "Etomidate.

 

In September of this year, the National Medical Products Administration, Ministry of Public Security, and National Health Commission issued a public announcement regarding the adjustment of the catalogue of anesthetic and psychotropic drugs. It states that methylphenidate will be included in the second category of the psychotropic drug catalogue, excluding drugs containing methylphenidate that have been approved for sale within China. This adjustment will take effect from October 1, 2023.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Belarusian committee discusses e-cigarette regulation, plans to restrict sales and public display
Belarusian committee discusses e-cigarette regulation, plans to restrict sales and public display
The Belarusian Council of the Republic met to discuss better legal regulation of e-cigarette systems, their circulation and use. It noted frequent requests to ban e-cigarettes and stop children/adolescents from picking up the habit, adding that proper laws here are long overdue to boost national healthy development and protect citizens’ rights.
Sep.23 by 2FIRSTS.ai
Netherlands’ Vrijdag Showcases Anti-Counterfeit and Eco-Friendly Cigar Band Designs in Dortmund; NFC and Multi-Band Trends Draw Attention
Netherlands’ Vrijdag Showcases Anti-Counterfeit and Eco-Friendly Cigar Band Designs in Dortmund; NFC and Multi-Band Trends Draw Attention
Ahead of the 2025 InterTabac trade fair, Vrijdag’s managing director Henk Nota highlighted how cigar bands are evolving from decorative elements into high-tech tools for branding, anti-counterfeiting, and sustainability. Trends include larger sizes, multi-band designs, eco-friendly materials, and NFC integration.
Sep.18
UK police seize over 30,000 illegal e-cigarettes, cigarettes, and tobacco products in large-scale raid in Warrington
UK police seize over 30,000 illegal e-cigarettes, cigarettes, and tobacco products in large-scale raid in Warrington
Over 30,000 illegal tobacco and e-cigarette products were seized in a large-scale operation by Warrington police on Thursday.
Oct.08 by 2FIRSTS.ai
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
British American Tobacco has paused the U.S. pilot launch of its unlicensed Vuse One vape amid intensified FDA enforcement.
Oct.28 by 2FIRSTS.ai
Singapore tightens vape enforcement, mandates rehab for etomidate users
Singapore tightens vape enforcement, mandates rehab for etomidate users
Singapore’s Ministry of Health (MOH) and Health Sciences Authority (HSA) reported that from Sep 1 to Oct 12, 1,339 people were caught for vape-related offences, including 102 found in possession of etomidate-laced vapes.
Oct.17 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai